BCV
XBI icon

Banque Cantonale Vaudoise’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Banque Cantonale Vaudoise’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$422K Sell
3,306
-279
-8% -$34.8K 0.02% 525
2025
Q4 		$437K Buy
+3,585
New +$411K 0.02% 470
2025
Q3 		– Sell
-827
Closed -$69K – 869
2025
Q2 		$69K Hold
827
– – ﹤0.01% 623
2025
Q1 		$67K Buy
+827
New +$73.9K ﹤0.01% 662
2024
Q3 		$124K Sell
1,253
-13,446
-91% -$1.32M 0.01% 531
2024
Q2 		$1.36M Buy
14,699
+500
+4% +$44.8K 0.05% 298
2024
Q1 		$1.35M Buy
14,199
+3,179
+29% +$295K 0.05% 315
2023
Q4 		$984K Sell
11,020
-2,617
-19% -$194K 0.04% 348
2023
Q3 		$995K Buy
13,637
+844
+7% +$67.4K 0.05% 319
2023
Q2 		$1.06M Buy
12,793
+1,021
+9% +$85.4K 0.05% 328
2023
Q1 		$898K Buy
11,772
+301
+3% +$25K 0.04% 329
2022
Q4 		$953K Buy
11,471
+3,526
+44% +$285K 0.05% 309
2022
Q3 		$631K Buy
7,945
+1,485
+23% +$125K 0.04% 438
2022
Q2 		$480K Buy
6,460
+31
+0.5% +$2.33K 0.02% 502
2022
Q1 		$578K Sell
6,429
-679
-10% -$62.7K 0.02% 519
2021
Q4 		$796K Sell
7,108
-1,427
-17% -$172K 0.03% 470
2021
Q3 		$1.07M Sell
8,535
-37
-0.4% -$4.76K 0.05% 401
2021
Q2 		$1.16M Buy
8,572
+225
+3% +$29.6K 0.05% 395
2021
Q1 		$1.13M Buy
8,347
+2,487
+42% +$372K 0.06% 341
2020
Q4 		$825K Buy
5,860
+3,397
+138% +$435K 0.05% 354
2020
Q3 		$274K Buy
+2,463
New +$276K 0.02% 607
2020
Q2 		– Sell
-1,328
Closed -$103K – 961
2020
Q1 		$103K Sell
1,328
-1,040
-44% -$92.1K 0.01% 766
2019
Q4 		$225K Buy
+2,368
New +$205K 0.02% 701

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Banque Cantonale Vaudoise's XBI Position: Q1 2026 in Review

Banque Cantonale Vaudoise reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 7.8% in Q1 2026, selling an estimated $34.8K and leaving 3,306 shares worth $422K. The position accounts for 0.02% of the portfolio, ranked #525.

Banque Cantonale Vaudoise first reported a position in XBI in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.36M in Q2 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Banque Cantonale Vaudoise held 3,306 shares of State Street SPDR S&P Biotech ETF worth $422K as of Q1 2026.
  • Banque Cantonale Vaudoise sold 279 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $34.8K.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #525 holding.
  • Banque Cantonale Vaudoise first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 23 quarters since.
  • Banque Cantonale Vaudoise's State Street SPDR S&P Biotech ETF position peaked at $1.36M in Q2 2024.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.